Browse the evidence

Brown adipose tissue (BAT) and beige/brite adipocytes within white adipose tissue (WAT) are metabolically active depots that can correct WAT pathologies and improve whole-body insulin sensitivity through thermogenesis mediated by UCP1.

You likely have metabolically active brown fat, even as an adult. While you can't 'eat' brown fat, you can potentially activate it through cold exposure or exercise, which may improve insulin sensitivity. This is a biological lever for metabolic health, distinct from simple calorie restriction.

Beige/brite adipocytes, found interspersed in white adipose tissue, can be recruited and transformed into a brown fat-like phenotype through mechanisms involving PRDM16, beta-3-adrenergic stimulation, and cold exposure.

Your white fat contains 'beige' cells that can be activated by cold. This process, mediated by PRDM16, turns fat into a heat-producing tissue, potentially improving metabolic health.

Roux-en-Y gastric bypass (RYGB) induces a progressive, adaptive rise in postprandial satiety hormones (PYY, GLP-1, enteroglucagon) and suppresses the compensatory rise in ghrelin, which explains the sustained weight loss and altered satiety without the typical counter-regulatory increase in appetite.

For individuals with morbid obesity, standard diet and exercise often fail long-term because the body increases hunger hormones (like ghrelin) to defend its higher weight. Roux-en-Y gastric bypass physically alters the gut to produce more satiety hormones (PYY, GLP-1) and suppresses hunger signals. This hormonal shift explains why patients feel fuller faster and stay full longer, leading to sustained weight loss without the typical rebound hunger seen in dieting. It is a physiological reset, not just a restriction.

High-protein diets (defined as >1.2 g/kg/day) cause intraglomerular hypertension and hyperfiltration, which may lead to kidney damage, proteinuria, and accelerated decline in eGFR, particularly in individuals with pre-existing chronic kidney disease (CKD) or risk factors.

If you are eating more than 1.2 grams of protein per kilogram of body weight daily, especially from animal sources, and you have any history of kidney issues, diabetes, or high blood pressure, you should monitor your kidney function (eGFR) regularly. Consider shifting some protein intake to plant sources to reduce acid load and phosphate burden, which may protect kidney health.

The ketogenic diet, by emphasizing high protein (1.2-2.0 g/kg) and high fat while excluding fruits/vegetables, may increase the risk of kidney stones, metabolic acidosis, and albuminuria due to high dietary acid load and lack of alkali precursors.

If you follow a ketogenic diet and have a history of kidney stones or kidney disease, be aware that the high acid load from animal proteins and lack of fruits/vegetables may increase your risk of stone formation and metabolic acidosis. Monitor your health and consider incorporating low-carb vegetables to balance acid load.

Adiponectin, des-acyl ghrelin, and leptin are adipokines that decrease insulin resistance and subsequently nonalcoholic fatty liver disease (NAFLD), whereas proinflammatory cytokines TNF-α and IL-6 enhance insulin resistance and promote NAFLD.

Your liver health is heavily influenced by hormones from your fat tissue. Maintaining a healthy weight and metabolic balance can improve levels of protective hormones like adiponectin and reduce inflammatory signals like TNF-α, thereby lowering the risk of fatty liver disease.

Leptin levels are elevated in obesity and NASH, correlating with hepatic steatosis severity, but leptin resistance may prevent its protective anorectic effects.

High leptin levels in obesity do not automatically lead to weight loss due to leptin resistance; addressing the underlying metabolic state is necessary to restore sensitivity.

Adipose tissue-specific overexpression of Vascular Endothelial Growth Factor (VEGF) protects against diet-induced obesity and insulin resistance by enhancing angiogenesis, increasing thermogenesis, and shifting macrophage polarization toward an anti-inflammatory M2 phenotype.

This research suggests that improving blood vessel density in adipose tissue (angiogenesis) may help prevent obesity and insulin resistance. In mice, this was achieved by overexpressing VEGF, which increased energy expenditure (thermogenesis) and reduced inflammatory markers. While not a direct human intervention, it highlights the importance of adipose tissue health and vascularization in metabolic function.

Activation of the alternative bile acid synthetic pathway, specifically via increased CYP7B1 expression and non-12α-hydroxylated bile acids (e.g., CDCA, TUDCA), improves glucose and lipid metabolism by reducing lipid absorption and enhancing energy expenditure.

Focus on dietary patterns or interventions that support the alternative bile acid pathway, such as consuming polyphenol-rich foods like Pu-erh tea (theabrownin) or fermented foods that may influence gut microbiota bile salt hydrolase activity. This shift favors non-12α-hydroxylated bile acids, which are associated with improved glucose tolerance and reduced lipid absorption in metabolic disease contexts.

Inhibition of intestinal bile salt hydrolase (BSH) activity by compounds like theabrownin or riboflavin increases conjugated bile acids in the distal ileum, which inhibits intestinal FXR signaling and upregulates hepatic CYP7B1, thereby promoting the alternative bile acid pathway.

Consider incorporating Pu-erh tea or other sources of theabrownin into your diet. These compounds may inhibit bacterial enzymes in the gut, leading to a favorable shift in bile acid signaling that supports metabolic health.

High levels of 12α-hydroxylated bile acids (derived from the classical pathway) are associated with metabolic disorders like insulin resistance and type 2 diabetes, whereas a higher ratio of non-12α-hydroxylated bile acids is beneficial.

Monitor bile acid profiles if possible; a lower ratio of 12α-hydroxylated bile acids (like cholic acid) to non-12α-hydroxylated bile acids (like chenodeoxycholic acid) may be a marker of better metabolic health.

Age-related sarcopenia and osteoporosis are driven by a decline in the GH/IGF1 axis, specifically through reduced circulating levels and impaired post-receptor signaling efficiency (e.g., IRS/PI3-K/AKT pathway) in muscle and bone cells.

As you age, your body's natural production of Growth Hormone and IGF-1 drops, and your cells become less responsive to them. This biological shift contributes significantly to muscle wasting and bone loss, independent of how much you exercise. Understanding this hormonal decline highlights the importance of maintaining muscle mass through resistance training and potentially exploring medical interventions for those with diagnosed deficiencies, rather than accepting tissue loss as an unavoidable fate.

Fucoxanthin improves insulin sensitivity and reduces blood glucose levels by down-regulating pro-inflammatory adipokines (TNF-α, MCP-1, IL-6) and regulating lipid metabolism enzymes.

Fucoxanthin may help manage blood sugar and insulin resistance by reducing inflammation in fat tissue and regulating enzymes involved in fat synthesis. This supports metabolic health, particularly for those with insulin resistance.

High-dose long-chain omega-3 supplementation (>4.4 g/day) may worsen glucose metabolism, including increasing the risk of diabetes diagnosis and raising HbA1c and fasting glucose.

If you are taking very high doses of omega-3 (more than 4.4 grams per day), be aware that this might negatively impact your blood sugar levels. While the evidence is not definitive, it suggests a potential risk of worsening glucose control at these high doses. Consult your doctor before maintaining such high doses.

Increasing alpha-linolenic acid (ALA) intake may increase fasting insulin levels by approximately 7%, but has little or no effect on other glucose metabolism markers.

If you are increasing your intake of alpha-linolenic acid (found in flaxseed, canola, and walnuts), be aware that it might slightly increase your fasting insulin levels. While the effect on blood sugar itself is negligible, this insulin change is worth monitoring if you have insulin resistance.

Aging induces a shift in mesenchymal stem cell lineage toward adipogenesis and away from osteoblastogenesis, driven by low-grade chronic inflammation (LGCI) from Western diets, resulting in osteosarcopenic obesity.

Focus on reducing inflammation through diet (increasing Omega-3s, decreasing Omega-6s) rather than just weight loss, as visceral fat drives the loss of bone and muscle in aging.

Resistant Starches (RS2, RS3) are lipid neutral, having no significant effect on serum lipids, while some nonabsorbable sugars (e.g., lactulose) may raise serum cholesterol.

Not all fiber works the same. Resistant starches (found in cooled potatoes/rice) do not lower cholesterol. Some nonabsorbable sugars like lactulose might even raise it. Focus on viscous fibers for cholesterol management.

Transfeminine hormone therapy is associated with an increased risk of venous thromboembolism (VTE), particularly with oral ethinyl estradiol or conjugated equine estrogen, whereas transdermal estradiol may mitigate this risk.

If you are a transgender woman on hormone therapy, be aware that oral conjugated equine estrogen carries a higher risk of blood clots than oral estradiol or transdermal estrogen. If you have risk factors like smoking, obesity, or a history of blood clots, discuss transdermal estrogen (patch/gel) with your doctor to minimize thrombotic risk.

Rotating shift work significantly increases the risk of metabolic syndrome and systemic inflammation (elevated leukocyte count) in male workers, independent of age and physical activity.

If you work rotating shifts, your body's internal clock is fighting your schedule, raising your risk for metabolic syndrome and inflammation regardless of how much you exercise. Prioritize sleep hygiene and consider 'chronobiotic' strategies like managing light exposure and meal timing to align with your shift, as standard lifestyle advice alone may not fully offset the biological disruption.

Administration of the fatty acid synthase inhibitor C75 reduces food intake and body weight in mice by inhibiting hypothalamic AMP-activated protein kinase (AMPK) activity, thereby decreasing neuropeptide Y (NPY) expression.

This research identifies a specific brain pathway where inhibiting fatty acid synthesis reduces hunger. While C75 itself is a research chemical and not a consumer supplement, the findings suggest that strategies which influence hypothalamic energy sensing (like AMPK activity) could be key to managing appetite. Current practical advice remains focused on sustainable dietary habits, but this highlights the biological complexity of hunger regulation.

Gut microbiota dysbiosis, specifically involving Escherichia Coli producing the CIpB protein, may contribute to eating disorder pathology by mimicking satiety hormones and triggering autoimmune reactions.

Current research suggests gut health may play a role in eating disorders, but it is not yet a primary treatment target. Focus on established treatments like nutritional rehabilitation and therapy. Future probiotics or microbiome-targeted therapies may emerge, but are not currently standard care.

Activation of the NR4A nuclear receptor subgroup (specifically Nur77 and Nor-1) mediates metabolic homeostasis in skeletal muscle and liver, where its loss leads to insulin resistance, impaired glucose clearance, and lipid accumulation, while its activation enhances glucose transport and fatty acid oxidation.

This research suggests that physical activity and certain dietary components act as signals to activate NR4A receptors (like Nur77 and Nor-1) in your muscles and liver. When these receptors are active, they help your cells take up glucose and burn fatty acids more effectively. Conversely, inactivity or high-fat diets may suppress these receptors, contributing to insulin resistance. While no specific 'dose' of exercise is prescribed here, the mechanism implies that regular metabolic stress (exercise) and nutrient sensing (diet) are required to maintain this protective signaling pathway.

Metabolic endotoxemia, driven by lipopolysaccharides (LPS) from Gram-negative bacteria translocating into the bloodstream, causes systemic inflammation and insulin resistance.

Reducing high-fat diets may help lower LPS levels and systemic inflammation. A diet that supports gut barrier integrity (e.g., through fiber and prebiotics) may help reduce metabolic endotoxemia and improve insulin sensitivity.

Psychological stress negatively impacts male fertility by reducing luteinizing hormone and testosterone pulsing, which in turn impairs spermatogenesis and sperm quality.

If you are trying to conceive, high levels of psychological stress can physically lower your sperm count and motility by disrupting hormonal signals. Managing stress through counseling or lifestyle changes may help improve semen quality, as stress is a modifiable factor.